Whitepaper

CPhI Annual Report 2020

CPhI Annual Report 2020

The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts, as well as the CPhI Pharma Industry Rankings (an annual executive survey of pharma professional). Now in its eight year and launched at the CPhI Festival of Pharma, the report is an essential read for executives looking to get a head-start today on the shape of tomorrow’s industry.

The rankings compile the answers from nearly 40 questions for 550 global executives, covering perceptions across the leading pharma economies for a range of indices including: ‘quality of API manufacturing’, ‘quality of FDF manufacturing’, ‘innovativeness’, ‘growth’ and ‘biologics manufacturing’ amongst many others.

This year’s expert submissions include contributions from ten experts spanning topics as diverse as CDMO capacity forecasts, biologics manufacturing, AI, and sustainability to macro supply chain geo-realignments, digital adoption and patient centricity. Running as a series of opinions and articles, the CPhI experts call upon their considerable commercial and technical acumen to prophesize the future direction, technologies, opportunities and threats in pharma.

The CPhI Annual Report 2020 includes 15 pages of survey data analysis – including the CPhI Pharma Index, executive supply chain concerns, COVID implications, and the national pharma rankings – 10 expert contributions, spanning 30,000 words and 74 pages of insights.

Still to come: Not content with one edition, later this year, CPhI will also be issuing a second supplementary CPhI Annual Report 2020, post the CPhI Festival of Pharma spanning 4 further articles and executive survey results looking ahead to 2021.